Home/Filings/4/0001209191-20-032826
4//SEC Filing

Basenese Lou 4

Accession 0001209191-20-032826

CIK 0001681682other

Filed

May 28, 8:00 PM ET

Accepted

May 29, 6:48 AM ET

Size

5.3 KB

Accession

0001209191-20-032826

Insider Transaction Report

Form 4
Period: 2020-05-28
Basenese Lou
Director
Transactions
  • Purchase

    Common Stock

    2020-05-28$0.91/sh+10,000$9,10089,068 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.89 to $0.92, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  • [F2]Includes unvested restricted stock units.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001809482

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 6:48 AM ET
Size
5.3 KB